Biote (BTMD): Director bought ~$99K
Andrew R Heyer, Director at Biote, bought ~$99K of Biote shares.
- ~$99K
- Approx. value · 25K sh @ $3.95
- 370K
- Holds after · shares reported
- Traded
- Mar 17, 2025
- Filed
- Mar 20, 2025
What stands out in this filing
- The purchase added 7.2% to the shares this insider held before it; the filing reports 370,201 shares, held indirectly afterwards.
- 25,000 shares at an average of $3.95 each, as reported on the form.
- 4 other insiders at BTMD also bought in the open market within 30 days.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 13, 2025Insider10% owner purchased ~$2.41M of BTMD shares in the open market
- Mar 14, 2025Insider10% owner purchased ~$372K of BTMD shares in the open market
- Mar 17, 2025 · this disclosureInsiderDirector purchased ~$99K of BTMD shares in the open market
What came next
- Mar 17, 2025Insider · 5 peopleInsiders: 5 purchases (~$908K)
- Mar 31, 2025Insider10% owner purchased ~$352K of BTMD shares in the open market
- Apr 3, 2025Insider10% owner purchased ~$24K of BTMD shares in the open market
- Apr 4, 2025Insider10% owner purchased ~$77K of BTMD shares in the open market
- Apr 7, 2025Insider10% owner purchased ~$137K of BTMD shares in the open market
- Apr 8, 2025Insider10% owner purchased ~$112K of BTMD shares in the open market
- Apr 9, 2025Insider10% owner purchased ~$43K of BTMD shares in the open market
- Apr 16, 2025Insider10% owner purchased ~$3.3K of BTMD shares in the open market
- Apr 17, 2025Insider10% owner purchased ~$23K of BTMD shares in the open market
- Apr 21, 2025Insider10% owner purchased ~$29K of BTMD shares in the open market
- Apr 30, 2025Insider10% owner purchased ~$6.4K of BTMD shares in the open market
- May 6, 2025Insider10% owner purchased ~$1.42M of BTMD shares in the open market
- May 7, 2025Insider10% owner purchased ~$39K of BTMD shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Biote
For Biote, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BTMD page.
Other recent filings by Andrew R Heyer, Director
- SEC Form 4 at Suncrete (RMIX)Nov 20, 2026
- SEC Form 4 at Suncrete (RMIX)Nov 20, 2026
- SEC Form 4 at Arko Petroleum (APC)Nov 19, 2026
- SEC Form 4 at OneSpaWorld Holdings Limited (OSW)Nov 4, 2026
- SEC Form 4 at OneSpaWorld Holdings Limited (OSW)Nov 4, 2026
The full history of Andrew R Heyer, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which Biote (BTMD) insider traded, and how much?
Andrew R Heyer, Director at Biote, bought ~$99K of Biote shares. 25K shares at $3.95, open market.
When did it happen, and when was it made public?
Traded: Mar 17, 2025. Filed: Mar 20, 2025. That is 3 days between the two dates.
What stands out in this filing?
The purchase added 7.2% to the shares this insider held before it; the filing reports 370,201 shares, held indirectly afterwards. 25,000 shares at an average of $3.95 each, as reported on the form. 4 other insiders at BTMD also bought in the open market within 30 days.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Biote recently?
For Biote, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BTMD page.
Does this mean BTMD stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Biote
- SEC Schedule 13GNov 12, 2026
- SEC Form 4Aug 12, 2026
- SEC Form 4Aug 12, 2026
- SEC Form 4May 8, 2025
- SEC Form 4May 8, 2025
- SEC Form 4May 2, 2025
Everything OQRO holds on this company is on its BTMD page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data